Comparative genomic hybridization studies have shown gains in chromosome region 2p as the most common imbalance in classi-cal Hodgkin lymphoma (cHL). The minimal region of gain contained 2 candidate onco-genes, REL and BCL11A. This study exam-ined the involvement of REL and BCL11A loci in 44 primary cases of cHL by combined immunophenotyping and interphase cytoge-netics (FICTION). A median 2p13 copy num-ber above the tetraploid range was detected in 24 (55%) cases. Adjustment for centro-mere 2 copy number indicated gains of 2p13 in 11 of 31 cHLs (35%) with 8 (26%) high-level amplifications. One cHL displayed se-lective amplification of the REL locus not affecting BCL11A; another case studied by FICTION and a cHL with cytogenetic 2p change i...
Lymphomas are a heterogeneous group of neoplasias originating from B- or T-lymphocytes. In this thes...
Hodgkin lymphoma (HL) is a malignant lymphoma that is diagnosed mostly in young adults, and is the s...
To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide a...
Amplifications of the c-Rel locus on chromosome 2p13-p16 have been described in distinct lymphoma su...
Hodgkin- and Reed-Sternberg (HRS) cells microdissected from 41 classical Hodgkin lymphomas (cHL) of ...
To identify genes involved in the pathogenesis of classical Hodgkin lymphoma (cHL), we performed ser...
Purpose: To determine the recurring DNA copy number alterations (CNA) in classical Hodgkin lymphoma ...
To determine whether recurrent genomic imbalances are a feature of HL, CD30-positive HRS cells were ...
In a recent issue of Blood, Mathas et al suggested elevated BCL3 expression to be functionally impor...
We studied the genomic status of BCL6 in 23 cases of nodular lymphocyte predomi-nance Hodgkin lympho...
In classical Hodgkin lymphoma (cHL) the mechanisms underlying primary refrac-tory disease and relaps...
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and T cell/histiocyte rich large B cell lymp...
Hodgkin\u2019s lymphoma (HL) is a heterogeneous lymphoid malignancy curable in more than 80% of case...
none15Secondary tumors and leukemias are major complications in Hodgkin lymphoma (HL). They likely a...
Mata et al.Defining the mutational landscape of classic Hodgkin lymphoma is still a major research g...
Lymphomas are a heterogeneous group of neoplasias originating from B- or T-lymphocytes. In this thes...
Hodgkin lymphoma (HL) is a malignant lymphoma that is diagnosed mostly in young adults, and is the s...
To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide a...
Amplifications of the c-Rel locus on chromosome 2p13-p16 have been described in distinct lymphoma su...
Hodgkin- and Reed-Sternberg (HRS) cells microdissected from 41 classical Hodgkin lymphomas (cHL) of ...
To identify genes involved in the pathogenesis of classical Hodgkin lymphoma (cHL), we performed ser...
Purpose: To determine the recurring DNA copy number alterations (CNA) in classical Hodgkin lymphoma ...
To determine whether recurrent genomic imbalances are a feature of HL, CD30-positive HRS cells were ...
In a recent issue of Blood, Mathas et al suggested elevated BCL3 expression to be functionally impor...
We studied the genomic status of BCL6 in 23 cases of nodular lymphocyte predomi-nance Hodgkin lympho...
In classical Hodgkin lymphoma (cHL) the mechanisms underlying primary refrac-tory disease and relaps...
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and T cell/histiocyte rich large B cell lymp...
Hodgkin\u2019s lymphoma (HL) is a heterogeneous lymphoid malignancy curable in more than 80% of case...
none15Secondary tumors and leukemias are major complications in Hodgkin lymphoma (HL). They likely a...
Mata et al.Defining the mutational landscape of classic Hodgkin lymphoma is still a major research g...
Lymphomas are a heterogeneous group of neoplasias originating from B- or T-lymphocytes. In this thes...
Hodgkin lymphoma (HL) is a malignant lymphoma that is diagnosed mostly in young adults, and is the s...
To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide a...